BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 21753180)

  • 1. Myopathy and neuropathy with pipestem capillaries and vascular activated complement deposition.
    Reimann J; Kornblum C; Tolksdorf K; Brück W; van Landeghem FK
    Neurology; 2011 Jul; 77(4):401-3. PubMed ID: 21753180
    [No Abstract]   [Full Text] [Related]  

  • 2. Pipestem capillaries in necrotizing myopathy revisited.
    Schröder NW; Goebel HH; Brandis A; Ladhoff AM; Heppner FL; Stenzel W
    Neuromuscul Disord; 2013 Jan; 23(1):66-74. PubMed ID: 23102899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Necrotizing myopathy with microvascular deposition of the complement membrane attack complex.
    De Bleecker J; Vervaet V; Van den Bergh P
    Clin Neuropathol; 2004; 23(2):76-9. PubMed ID: 15074581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. X-linked vacuolated myopathy: complement membrane attack complex on surface membrane of injured muscle fibers.
    Villanova M; Louboutin JP; Chateau D; Eymard B; Sagniez M; Tomé FM; Fardeau M
    Ann Neurol; 1995 May; 37(5):637-45. PubMed ID: 7755359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Role of C5b-9 expression in skeletal muscle blood vessels in necrotizing myopathy].
    Cong L; Pu C; Mao Y; Liu J; Lu X; Wang Q
    Nan Fang Yi Ke Da Xue Xue Bao; 2012 May; 32(5):714-7. PubMed ID: 22588932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Necrotizing myopathy with pipestem capillaries, microvascular deposition of the complement membrane attack complex (MAC), and minimal cellular infiltration.
    Emslie-Smith AM; Engel AG
    Neurology; 1991 Jun; 41(6):936-9. PubMed ID: 2046947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Necrotizing myopathy with pipestem capillaries and minimal cellular infiltration: a case associated with cutaneous signs of dermatomyositis.
    Authier FJ; Kondo H; Ghnassia RT; Revuz J; Gherardi RK
    Neurology; 1996 May; 46(5):1448-51. PubMed ID: 8628498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amyloid myopathy: clinicopathologic study of 16 cases.
    Prayson RA
    Hum Pathol; 1998 May; 29(5):463-8. PubMed ID: 9596269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amyloid myopathy presenting with rhabdomyolysis: evidence of complement activation.
    Rodolico C; Mazzeo A; Toscano A; Pastura C; Maimone D; Musumeci O; Musolino C; Vita G
    Neuromuscul Disord; 2006 Aug; 16(8):514-7. PubMed ID: 16919949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myopathy associated with anti-signal recognition peptide antibodies: clinical heterogeneity contrasts with stereotyped histopathology.
    Dimitri D; Andre C; Roucoules J; Hosseini H; Humbel RL; Authier FJ
    Muscle Nerve; 2007 Mar; 35(3):389-95. PubMed ID: 17143889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune-mediated neuropathy and myopathy in post-streptococcal disease: electron-microscopical, morphometrical and immunohistochemical studies.
    Sommer C; Schröder JM
    Clin Neuropathol; 1992; 11(2):77-86. PubMed ID: 1318816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dermatomyositis-associated sensory neuropathy: a unifying pathogenic hypothesis.
    Nguyen TP; Bangert C; Biliciler S; Athar P; Sheikh K
    J Clin Neuromuscul Dis; 2014 Sep; 16(1):7-11. PubMed ID: 25137509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-necrotizing autoimmune myopathy with pipestem type capillaries - a light and electron microscopic study.
    Janzen RW; Weber M; Schlote W
    Clin Neuropathol; 2012; 31(2):81-6. PubMed ID: 22385789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paraneoplastic myopathy: response to intravenous immunoglobulin.
    Sampson JB; Smith SM; Smith AG; Singleton JR; Chin S; Pestronk A; Flanigan KM
    Neuromuscul Disord; 2007 May; 17(5):404-8. PubMed ID: 17336069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Muscle and nerve biopsies: techniques for the neurologist and neurosurgeon.
    Mikell CB; Chan AK; Stein GE; Tanji K; Winfree CJ
    Clin Neurol Neurosurg; 2013 Aug; 115(8):1206-14. PubMed ID: 23769866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteolysis of beta-dystroglycan in muscular diseases.
    Matsumura K; Zhong D; Saito F; Arai K; Adachi K; Kawai H; Higuchi I; Nishino I; Shimizu T
    Neuromuscul Disord; 2005 May; 15(5):336-41. PubMed ID: 15833425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Muscle and nerve pathology in Dunnigan familial partial lipodystrophy.
    Spuler S; Kalbhenn T; Zabojszcza J; van Landeghem FK; Ludtke A; Wenzel K; Koehnlein M; Schuelke M; Lüdemann L; Schmidt HH
    Neurology; 2007 Feb; 68(9):677-83. PubMed ID: 17325275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case of amiodarone and neuromyopathy.
    Silva Oropeza E; Peralta Rosado HR; Valero Elizondo C; Sadowinski E; Magaña Serrano JA
    Rev Invest Clin; 1997; 49(2):135-9. PubMed ID: 9294958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adult polyglucosan body myopathy with subclinical peripheral neuropathy: case report and review of diseases associated with polyglucosan body accumulation.
    Weis J; Schröder JM
    Clin Neuropathol; 1988; 7(6):271-9. PubMed ID: 2852083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysmyelinating sensory-motor neuropathy in merosin-deficient congenital muscular dystrophy.
    Di Muzio A; De Angelis MV; Di Fulvio P; Ratti A; Pizzuti A; Stuppia L; Gambi D; Uncini A
    Muscle Nerve; 2003 Apr; 27(4):500-6. PubMed ID: 12661054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.